Key Takeaways
- UiPath delivers Q2 fiscal 2027 earnings Thursday, September 3, following the closing bell
- Analysts project non-GAAP EPS of $0.15 with revenue hitting $397.85M, aligning with the upper end of guidance
- PATH shares have surged approximately 40% in the last month, currently trading near $18.15
- Critical metrics include ARR expansion, net retention figures, and progress in agentic AI deployment
- The company has surpassed both earnings and revenue projections in 7 out of its most recent 8 quarters
UiPath (PATH) will unveil its fiscal 2027 second-quarter earnings this Thursday, September 3, following the conclusion of regular trading hours. Shares currently hover around $18.15, reflecting a remarkable surge of nearly 40% during the preceding month.
The Street’s consensus calls for non-GAAP earnings per share of $0.15 alongside revenue totaling $397.85M. This revenue projection sits comfortably within management’s forecasted range of $395M to $400M, leaning toward the upper bound.
During the previous quarter, UiPath delivered revenue of $418.4M, representing a year-over-year increase of 17.3%. Annual Recurring Revenue reached $1.901B, climbing 12%, while the dollar-based net retention rate stood at 109%.
The automation software provider also achieved a significant milestone in Q1 with its inaugural GAAP operating profit of $27.99M. This profitability marker caught the attention of market participants.
For the current quarter, Wall Street analysts are projecting revenue expansion of approximately 10% compared to the prior year. This represents a deceleration from the 14.4% growth rate achieved during the comparable period twelve months ago.
Company leadership has provided guidance targeting Q2 ARR between $1.929B and $1.934B, along with non-GAAP operating income approaching $75M. These figures will receive substantial scrutiny from market observers.
UiPath has exceeded both earnings per share and revenue consensus estimates in seven out of its past eight quarterly reports. This consistent performance record provides optimism among bullish investors approaching Thursday’s announcement.
Diverging Analyst Perspectives
Wall Street opinion remains divided on the stock’s prospects. SA analyst Investing Smart maintains a “Hold” stance, citing intensifying competitive dynamics, a more conservative full-year growth trajectory, and significant short interest comprising roughly one-third of the publicly traded shares.
Such elevated short interest levels create conditions for pronounced volatility in either direction following the earnings release. This dynamic warrants investor attention.
Conversely, SA analyst Danil Sereda assigns a “Buy” rating to the shares. His thesis anticipates UiPath will exceed Q2 revenue expectations and achieve its $1.93B ARR target, supported by the company’s robust cash reserves, profitability trajectory, and opportunities within agentic AI applications.
The consensus price target among analysts stands at $13.87, notably below the present trading level of $18.08. This discrepancy represents an important consideration for shareholders and prospective investors.
Critical Factors Beyond Headline Figures
While revenue and earnings per share metrics are important, they won’t provide the complete picture. Investor attention will concentrate on ARR trajectory, net retention performance, and momentum in agentic AI customer adoption.
Company executives have highlighted preliminary indicators of business re-acceleration, notably an 18% year-over-year expansion in clients generating over $1M in ARR. This customer growth metric will face intense examination during the earnings call.
Competitive threats from Microsoft (MSFT), OpenAI, and emerging AI-focused competitors continue to pose challenges. Stakeholders will be listening for management’s strategic positioning and differentiation plans.
On a year-to-date basis, PATH has advanced 12.08%, marginally outperforming the S&P 500’s 11.48% return. However, the stock has gained only approximately 1% during the past week, indicating investors are adopting a wait-and-see approach before the results.
Sell-side analysts tracking the company have maintained relatively stable estimates throughout the past 30 days, suggesting expectations for results that align closely with current consensus forecasts.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
